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Efficient tumor cell invasion into the surrounding
desmoplastic stroma is a hallmark of cancer progression and
involves the navigation through available small tissue spaces
existent within the dense stromal network. Such navigation
includes the reciprocal adaptation of the moving tumor cell,
including the nucleus as largest and stiffest organelle, to pre-
existent or de-novo generated extracellular matrix (ECM)
gaps, pores and trails within stromal compartments. Within
the context of migration, we briefly summarize physiological
and tumor-related changes in ECM geometries as well as
tissue proteolysis. We then focus on mechanisms that ensure
the successful translocation of a nucleus through a confining
pore by cytoskeleton-mediated coupling, as well as regulators
of cell and nuclear deformability such as chromatin
organization and nuclear lamina expression. In summary,
understanding dynamic nuclear mechanics during migration
in response to confined space will add to a better conceptual
appreciation of cancer invasion and progression.
Space Negotiation in Cancer Cell Migration
Cell migration in vertebrates plays an essential role during
embryonic development after which most body cells become resi-
dent. An exception form for example leukocytes involved in
immune surveillance. In principle, cells have the capacity to re-
activate their migratory capacity when required, for example dur-
ing tissue regeneration, but also in a number of pathologies, such
as in cancer. After cancerous transformation, neoplastic cells fol-
low a step-wise cascade that contributes to disease progression.1,2
Cancer cells that undergo an epithelial-to-mesenchymal transi-
tion process escape their primary location by basement mem-
brane penetration and detachment from a cell collective by
complete or partial downregulation of cell-cell junctional mole-
cules resulting in the formation of small cell groups or single
cells.3 The concomitant onset of invasion through tumor-related
densified and remodeled connective tissues contributes to hema-
togenous or lymphogenous dissemination for subsequent distant
metastasis formation and eventually fatal outcome.
The mechanistic process of cell movement that underlies inva-
sion was originally studied over smooth surfaces and consists of a
number of consecutive steps (steps 1, 2, 4, and 5 in Fig. 1A).4
These steps, when repetitively carried out, result in forward loco-
motion of the cell body, which includes the co-locomotion of the
nucleus as largest and stiffest cargo in a cell.
These basic requirements for forward locomotion can be
adapted or receive additional ‘input’ dependent on specific
molecular or physical cellular or environmental determinants.
Important examples are spatial extracellular matrix (ECM)
organizations, which include both a guidance or barrier function
for the forward locomoting cell. When space is sparse, moving
cells negotiate for physical space by either removing constricting
fibers by focalized proteolysis, or adapting their shape to the pre-
existing, only slightly bendable, fibrillar ECM network.
‘Focalized ECM fiber cleavage’ was previously established as an
additional migration step in dense environments that follows ini-
tial contractile forward pulling to advance the cell body. Tissue
proteolysis typically applies to mesenchymal cell types like fibro-
blasts during wound healing processes or aggressively moving
tumor cells. Migratory cell shape adaptation in response to lim-
ited space is another established principle in migration. It applies
for cells migrating through dense tissue structures in the absence
of tissue proteolysis, like tumor cells after blocking of proteolysis.
Shape changes also apply to fast moving antigen-scanning
immune cells by actomyosin contractility-mediated cell and
nuclear deformation.5-7,9 We therefore here extend the concept
on proteolytic cell-matrix interaction by the term “space
negotiation”, which includes cell-derived proteolytic ECM
remodeling, shape change of the cell, and deformation of the tis-
sue (Fig. 1A). In conjunction, the negotiation of the migrating
cell for physical space consists of 2 extreme states (Fig. 1B).8
One state, depicted at top, represents the sufficiency of physical
space for barrier-free migration together with the lack of defor-
mation of the co-migrating nucleus (Fig. 2A and B). The other
state, depicted at bottom, represents sparse space combined with
the incapability of ECM degradation which forces the moving
cell into compensatory amoeboid shape adaptation. Here, cell
body and nucleus deform to adapt to and pass through tissue
gaps smaller than the cell’s original cross-section (Fig. 2C).7
Between both states, a combination of space generation mecha-
nisms and deformation occurs in a graded fashion, preferentially
at lower proteolytic rates, in highly confining matrix geometries,
or upon fast migration with incomplete contact-dependent fiber
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breakdown. Thus, physical space negotiation during cell migra-
tion is the reciprocal interplay of using existing or generated space
devoid of solid ECM structure and the pliability of the cell, in
particular the nucleus. In this review we will discuss mechanisms
of space negotiation, starting with a short summary on compo-
nents that dictate space availability and then focus on cell mor-
phology-based adaptation mechanisms. Space availability is
determined by the (1) ECM geometries and matrix proteolysis,
whereas space adaptation involves cellular mechanisms to (2)
translocate a nucleus through constricting space for migration,
together with (3) components for nuclear deformability and (4)
consequences for migration in confined space. The principles of
space negotiation also apply to other cell types, in particular leu-
kocytes during immune surveillance. The leukocytes pass
through narrow pores imposed by vessel walls and connective tis-
sues and show remarkable abilities to adapt to pre-given tissue
structures by nuclear deformations. In this review, however we
remain focused on tumor cells and refer the reader to other work
highlighting mechanisms of immune cell migration.6,7,9,10,11
Physical 3D ECM geometries for cell migration
The physical ECM scaffold geometry of stromal connective
tissues derives from a number of chemical and physical compo-
nents. These include density and crosslink status of fibrillar pro-
teins, like collagen and elastin, which determines specific physical
fiber organization, alignment, as well as overall and local stiffness
values. This results in heterogeneous geometry of ECM-free
spaces of least resistance, referred to as gaps, pores and trails that
may provide guidance as well as constraints to cells, depending
on the tissue region.12-14 In dermal connective tissues, 3D ran-
dom loose ECM networks of the upper dermis layer merge into
aligned packed bundles in the deep dermis, whereas in sub-der-
mis regions fibers intersperse between fat cells and muscle
layers.14,15
During cancer progression, stromal cells like fibroblasts or
macrophages become ‘activated’ which often leads to reorganiza-
tion of the matrix that surrounds the proliferating tumor mass,
together with a fibroblast-mediated increase of ECM density and
stiffness.16-18 This results in further enhanced physico-chemical
ECM heterogeneity with altered anatomical pore spacing, includ-
ing small trails and clefts that newly appear between stiffened and
straightened ECM fibrils. Even though ECM-invading cells may
transiently deform or slightly widen compliant fibrils by actomy-
osin-mediated pushing, the resulting ECM structures provide
confined spacing to forward moving cell bodies.19 In conse-
quence, cancer cells employ a number of strategies to ‘negotiate’
limited ECM space.
Contact-dependent proteolysis
of ECM constrictions
ECM degradation can be executed by different enzyme classes,
such as matrix metalloproteinases (MMPs), but also cathepsins,
or serine proteases.20-23 These enzymes, besides having many
other pro-migratory substrates, degrade ECM by different modes
of proteolysis, such as intracellular, diffusive or cell-surface asso-
ciated.21,22,24 ECM contact-dependent proteolysis executes the
controlled degradation of ECM polymers that touch and con-
strict the cell surface. Example cell surface-associated proteases
are MMP-2 bound to avb3 integrins, the urokinase plasminogen
activator type (uPA), or membrane-tethered (MT) cell surface
proteases, like the matrix metalloproteinase MT1-MMP, in con-
junction with ß1 integrins.20,22,25 Cell surface associated proteol-
ysis results in the generation of a de novo ECM-free path that
matches the cross section of the forward moving cell.7,26,27 Note-
worthy, increased stroma stiffness leads to enhanced cell contrac-
tility and elevated MMP activity which correlates with enhanced
invasion of surrounding tissue structures.28 However, when
tumors of low ECM degradation capability are surrounded by
high ECM density, successful tumor migration requires in addi-
tion the morphological adaptation of the cell body to the narrow
constrictions provided by the matrix.
Figure 1. Physical space negotiation for migration: space availability ver-
sus space adaptation. (A) The five-step model of cell migration through
constricting 3D ECM matrix. For forward movement a cell must (1) polar-
ize and protrude into the matrix, followed by (2) adhesion to the ECM
substrate (red tips). Heterogenous ECM matrices might contain densely
packed fibrils (red circle) that demand for (3) the negotiation of physical
space by the cell, either by proteolytic cleavage of surrounding ECM, or
by cellular and nuclear deformation. Migration induced forces and coun-
terforces by confining ECM (blue arrows) and rigid nucleus (gray arrows)
are indicated. (4) Through actomyosin contraction the cell builds up trac-
tion force, and together with (5) de-adhesion (red outline) and retraction
from the rear, slides forward for migration. Black arrow, direction of
migration. (B) The ‘Yin-Yang’ of physical space negotiation as a function
of ECM free space availability and respective cell adaptation. Available
space results from ECM structure and cell-derived tissue proteolysis, and
is sufficient in the upper part but limited in the left lower corner of the
green triangle. Likewise, the capability to adapt to space lies in the
capacity of cell and nucleus to deform, and is highest in the lower part
but abrogated in the right upper corner of the pink triangle. The terms
‘Mesenchymal’ and ‘Amoeboid’ relate to established migration modes,
including the by us previously established term ‘amoeboid deformation’
after loss of proteolysis (Table 1 and see ref.7). Likewise, amoeboid
deformation applies to leukocyte migration when transmigrating small
tissue spaces.10,11
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Cellular and nuclear deformability
Cells are endowed with the capacity
to adapt to extracellular tissue structures,
an essential function for the build-up
and maintenance of healthy tissues.
Examples are thin peripheral nerve cone
extensions along solid structures such as
vessels or myofibers, or morphological
adaptation of collagen-producing fibro-
blasts within the highly ordered tissue
structures of tendons.29,30 Within the
cell, the soft cytosol has the highest abil-
ity to adapt, whereas the nucleus con-
tains 2–10 times higher stiffness
(Ddeformability, elasticity) values.31,32
Nuclear elasticities derive from a number
of determinants that include (1) the level
of chromatin compaction as well as (3)
the composition of the nuclear lamina in
the nucleus. It is speculated that intranu-
clear actin forms a nuclear scaffold
together with chromatin and lamins that
contributes to nuclear stiffness.33,34 Stiff-
ness levels of nucleus and cytoplasm are
highly interdependent and, together, are
determined by tissue type and differenti-
ation stage of the organism. For exam-
ple, stiffness levels are lowest in fat,
medium in connective tissue, and high-
est in bone.35,36 In addition, cellular and
in particular nuclear elasticities increase
from fetal development into adulthood,
and often decrease during transforma-
tion from healthy quiescent to neoplastic
proliferating tissue.37,38 Taken together,
as a general principle the nucleus
remains a relatively stiff and large organ-
elle, which has implications for the for-
ward migration of cells.
Consequences of space negotiation on migration efficacy
The available space determines if and to what extend adapta-
tion by cell and nuclear deformation is required, which together
influence migration efficacy (Fig. 1B; Table 1).7,12 Physical
space availability is defined by a combination of intrinsic matrix
geometry, matrix deformability defined by stiffness and compli-
ance, as well as by the capacity of the migrating cell to generate
proteolytic de novo tracks within the matrix.7,19 For proteolytic
migration, this combination maintains migration in all porosi-
ties, with highest migration efficacy at optimal pore size. Here,
proteases degrade peripheral ECM the mesenchymal cell is
“touching”. In increasing ECM densities, pore degradation
together with minor deformation of the otherwise ellipsoid
nucleus occur, leading to some decrease, but no abrogation, of
migration rates. Of note, at oversized pores migration rates
decrease again and proteases degrade surrounding matrix only as
a ‘bystander effect’.12 In the absence of proteolysis, oversized and
optimal pore sizes maintain migration rates, whereas in confined
spaces migration is somewhat reduced as compared to proteolytic
migration, but compensated by cellular and nuclear adaptation,
referred to as amoeboid deformation (Fig. 2C).7,22 Very small
pore size leads to the abrogation of migration, when the original
cross-section of the nucleus is reduced by 90% or more due to
deformation, defined as the ‘physical limit of migration’
(Fig. 2D).7 This migration abrogation phenotype is character-
ized by the formation of long cytoplasmic extensions (middle col-
umn). Together, both proteolytic and non-proteolytic migration
depend on net matrix-free space in a bi-phasic manner, where
migration is highest at pore sizes that optimally fit the locomot-
ing cell body and decline at mesh sizes that either exceed or limit
the cell body. However, in substrate pores that confine or limit
the cell, non-proteolytic migration rates decline much faster
(Table 1).7,39 Generally, for migration in confined space, intact
Figure 2. Cell and nuclear deformation depend on matrix density. HT1080 fibrosarcoma cells migrated
in collagen lattices of different pore sizes ranging from over-sized to limiting relative to the moving
cell’s cross section and in the presence of MMP inhibitor GM6001 to inhibit collagen degradation. Cells
were fixed after 5–15 hours and stained for F-actin and DNA, and imaged by confocal microscopy (for
more methodical details see ref.7). (A, B) Typically, for migration in unrestricted space, interphase cells
elongate and the ellipse-shaped co-migrating nucleus forms a cross sectional diameter of 7–10 mm
(see arrowheads). Tissue-free spaces that (A) exceed or (B) match cell size, allow cell migration inde-
pendent of further nuclear adaptation. (C) If the ECM confines the migrating cell, space negotiation is
inevitable and causes nuclear deformation and adaption to available tissue cross sections (arrow-
heads). (D) When ECM-free pores are <1/10 of the original nuclear cross section, migration is ablated.
This is indicated by nuclear deformations with cross-sectional diameter smaller than 3 mm7 Trans,
transmission. All numbers in mm indicate nuclear diameters between the arrowheads pointing to
smallest nuclear diameters. Arrow, direction of migration. All bars, 10 mm.
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integrin-mediated adhesion coupled to actin contractility (here
termed ‘mechanocoupling’) is crucial and, if disturbed, will lead
to early abrogation of migration (Table 1, see column ‘Migration
efficacy’). Thus, successful migration despite limited space
depends on intact mechanocoupling, together with significant
deformability of the nucleus.7 In summary, space negotiation for
efficient migration depends on (1) net ECM density, together
with (2) translocation of the nucleus by actomyosin contractility
coupled to ECM adhesion except for leukocytes and (3) the capa-
bility of the nucleus for deformation.
Nuclear Translocation for Migration
Cell movement over a surface requires the basic ‘ingredients’
that consist of cell polarity, protrusion, adhesion, contractility and
retraction processes that, when in tune, mediate the forward
migration of cell and consequently the nucleus.4,40 Cell migration
through 3-dimensional networks of limited space in addition
requires the ability of the cell to transport the rigid nucleus against
matrix-induced resistance (Fig. 3 [1]). A successful translocation
in general, but even more so when tight space must be negotiated,
requires the coordinated application of cell-intrinsic forces for (a)
proper positioning, (b) anterior pulling and posterior pushing
(Fig. 3 [2]), respectively, together with (c) the active deformation
of the nucleus. These functions depend fully or in part on the
direct connection of the cytoskeletal components to the nucleus
via the linker of nucleoskeleton and cytoskeleton (LINC) complex.
The LINC complex consists of SUN protein trimers that bind to
KASH-domain containing proteins, such as nesprins.41 SUN pro-
teins anchor in the nuclear lamina that underlies the double
nuclear membranes designated as ‘nuclear envelope’, whereas
nesprins bind, either directly or via further linker proteins, to
actin, microtubuli and intermediate filaments (Fig. 3 [3]).5,42
Nuclear re-orientation and positioning processes within the cell
take place prior to but also during migration. Initial backward
nuclear movement is mediated by microtubules and actomyosin,
which together orient and position the nucleus during cell polariza-
tion.43,44 Actomyosin-based movements result from special LINC
complex organizational structures, transmembrane actin-associated
nuclear (TAN) lines that directly link the nucleus to the actin
cytoskeleton. Consistently, the absence of SUN proteins or
lamin A disturbs the LINC-cytoskeleton axis and thus nuclear
positioning for efficient migration.44-46 Future experiments should
Table 1. Space availability and cell adaptation to space together dictate migration efficacy. Summary of pore sizes relative to cell size within ECM (left
column) that determine proteolytic and non-proteolytic migratory phenotypes (middle column) and migration efficacy (right column). Nuclei, yellow;
cell cytoplasm, red; ECM degradation into pore fragments, green. Intact mechanocoupling (indicated as red shadowed area in column on the right; adapted
from ref7).
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demonstrate whether nuclear positioning is elemen-
tary for migration through restricted space.
Next, at the onset of migration, integrins located
at the protruding leading edge bind to anterior
matrix fibers, and together with concomitant Rho/
ROCK-mediated actomyosin coupling and contrac-
tion, generate the necessary force to pull the nucleus
forward.47,48 Whereas actomyosin-mediated ante-
rior pulling forces require the presence of the LINC
complex connection to the nucleus, myosin II activ-
ity-mediated posterior nuclear ‘pushing’ by physical
force is in principle sufficient to transport the
nucleus forward (reviewed in42). The importance of
overall actomyosin contractility for nuclear defor-
mation along with forward movement of both can-
cer- and immune cells through 3-dimensional
confined space has been demonstrated after ROCK
or myosin II inhibition.7,9 After myosin II inhibi-
tion the deformation of nuclei together with the for-
ward locomation of dendritic cells through dense
collagen matrix was abrogated.9
Finally, transport of the nucleus through confined
space includes the adaptation of nuclear shape, which
might be thought of as a passive process for the
dragged nucleus. However, mechanisms that actively
deform the nucleus may help cells to transmigrate
confining pores and might be essential for forward
locomotion in 3D confined ECM matrices. On a
stiff glass surface, deformation and flattening of the
nucleus occurs by ‘perinuclear actin caps’.49 This
highly contractile structure is located basally and api-
cally of the nucleus thereby confining and actively
deforming it.48,50 Further, intermediate filaments,
such as vimentin, trap nuclei in a cage-like structure
and mediate the re-shaping of the nucleus in response
to externally applied or actomyosin-generated forces.51 Within a
dense constriction, these cytoskeletal structures are implicated in
tightly ‘wrapping’ around the nucleus to help the cell to translo-
cate through narrow constrictions. Like TAN lines, the actin cap,
as well as intermediate filaments, are physically connected to the
nucleus by the LINC complex. Consequently, LINC complex dis-
ruption disorganizes nucleo-cytoskeletal-related nuclear deforma-
tion and leads to impaired migration.49,52
In conclusion, cytoskeleton-mediated orientation, pulling/
pushing, as well as active deformation of the nucleus support the
co-locomotion of this rigid organelle during cell migration over
surfaces, and presumably through confining space. The effort for
active deformation of the nucleus might vary considerably, based
on its intrinsic organization and resulting rigidity.
Components and Regulators of Nuclear
Deformability
The rigidity, or deformability, of a cell nucleus as an impor-
tant spatial determinant in migration is primarily mediated by
(1) chromatin as well as nucleoskeletal organization and (2)
expression and assembly of lamins as part of the nuclear lamina.
We here summarize the structure of these mediators, with a focus
on chromatin and lamins, together with their regulation, espe-
cially by ECM stiffness.
Mediators of nuclear rigidity and integrity
The organization of nuclear chromatin largely determines the
size of the nucleus as well as the stiffness of the nuclear inte-
rior.53-55 Chromatin organization underlies a dynamic process
that includes chromatin doubling from G1 to G2 cell cycle
phase, or transcription-related euchromatin/heterochromatin
ratios that depend on the developmental, functional or diseased
cell stage.56,57 Chromatin decompaction from hetero- toward
euchromatin is mediated by histone acetylation where histone
acetyltransferases catalyze the addition of an acetyl group that
reduces the affinity between histones and DNA.58 This induces
increased transcription activity by enhanced accessibility for
RNA polymerase and transcription factors.59,60 Chromatin
decondensation therefore leads to nuclear size increase as well as
nuclear softening.53,55 This was experimentally demonstrated
Figure 3. Space negotiation during migration: nuclear translocation for migration
through confining pore size. The transport of the nucleus is challenged by [1] ECM-
induced constraints and depends on [2] intact mechanocoupling at both front and rear
of the cell. Translocation further depends on the [3] deformability of the nucleus, mainly
regulated by chromatin and lamins. Color codings, main figure: red, actin fibers; light
brown, ECM fibers; blue, nucleus; black line around nucleus, nuclear envelope; green,
LINC complex (depicted here only at schematized pulling actin fibers). Further, not
included here, are the possible involvement of nucleus-spanning contractile fibers and
TAN lines involved in the retrograde flow of the nucleus. Arrows, direction of force.
Insert: [3], stiffness-mediating structures chromatin and lamin, shown together with the
nuclear envelope and LINC complex. Color-coded legend, bottom left.
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after pharmacological inhibition by histone deacetylase inhibitor
trichostatin A by micropipette aspiration and atomic force
microscopy-mediated nuclear intendation.53,61
Vice versa, chromatin compaction from eu- toward hetero-
chromatin is mediated by histone de-acetylation or histone meth-
ylation.56,63 De-acetylation removes a negatively charged acetyl
group from a lysine residue within the N-terminal tail of the his-
tone, which enhances the affinity of the histone and the DNA,
thereby increasing compaction. Likewise, histone methylation by
the methylase inhibitor 5-deoxy- 50-methylthioadenosine, as well
as the addition of divalent cations to cells, implies chromatin
condensation and is associated with nuclear stiffening.37,63 In
conclusion, chromatin organization and compaction reduce size,
but increase stiffness of the nucleus.63,64
The nuclear lamina as part of the nuclear envelope fulfills a
major role in maintaining the stability and integrity of the
nucleus, and is further involved in anchoring and positioning,
sizing, shaping and stiffening of the nucleus.65-67 To fulfill these
plethora of functions, the lamina forms a structure that envelopes
the entire nucleus, as well as part of the intranuclear skeleton,
and consists of a dense fibrillar network of type V-intermediate
filaments, the lamins. The lamina associates with membrane pro-
teins, such as emerin, lamin B receptor (LBR), SUN proteins,
lamin associated polypeptide 1 and 2 (LAP1, LAP2), barrier to
autointegration factor (BAF), nurim, otefin, and MAN1.68-70
This organization allows specific interactions with neighboring
cellular components, the cytoskeleton to the outside, and chro-
matin to the inside (Fig. 3 [3]).5,71,72 Whereas, as outlined
before, lamina interactions to the cytoskeleton are mediated by
the LINC complex, interactions with chromatin are mediated by
direct and indirect associations. These involve heterochromatic
structures that are located at the nuclear periphery, the lamin-
associated domains (LADs), as well as chromatin interactions
within the intranuclear skeleton.73,74 Direct lamin-chromatin
associations were shown for the B-type lamin Dm0 in Drosoph-
ila, and involve the lamin B evolutionary conserved nuclear local-
ization sequence (NLS) domain and the TRAT amino acid
sequences with the N- and C-terminal tail domains of core histo-
nes.62,75 Indirect lamin-chromatin interactions are mediated by
lamin-associated emerin and LAP proteins, where emerin is
involved in mechanotransduction and LAP2 a maintains gene-
poor and transcriptionally silent structures of heterochroma-
tin.76,77 Thus, the lamina plays an important role to regulate
chromatin dynamics and organization.
The lamins, as part of the nuclear lamina, are separated into
A- and B-type and contain 7 different lamin protein members,
which are encoded by 3 distinct lamin genes in the human
genome. Whereas A-type lamins are a splicing variant of one
transcript (lamin A, C, C2, AD10) from the LMNA gene located
at chromosome 1q21.1–21.3, B-type lamins derive from 2 dis-
tinct genes: LMNB1 (lamin B1) located at chromosome 5q23.3-
q31.1, and LMNB2 (lamin B1 and B3) present on chromosome
19p13.3. The expression of the lamin subtypes is dependent on
cell type and differentiation state and changes between embry-
onic development, adulthood and cancer. During development,
proliferating soft stem cells express B-type lamins, in particular
B2, but lack A-type lamins.78 During cell differentiation, A-type
lamins are upregulated, which correlates with increased nuclear
stiffness, consistent with an increase of the lamin A:B stoichiome-
try.36,79 An exception is formed by polymorphonuclear neutro-
phils (PMN’s), which further decrease their already low lamin A/
C levels during further maturation.80 Concomitantly, PMN’s
upregulate lamin B receptor for the increase of nuclear mem-
brane surface area, which together causes the formation of soft
and lobulated nuclei.81,82 Consequently, mature neutrophilic cell
nuclei contain a high pliability and small cross-section, which
allows rapid vessel- and tissue transmigration for the performance
of effector function.
While, with the exception of neutrophils, in healthy tissue cells
the presence of A-type lamins is mostly associated with cell quies-
cence and differentiation, de-differentiation may again induce
reduction of lamin A/C.83 Therefore, the downregulation of lamin
A/C in many cancers, i.e. leukemia’s, lymphoma and small cell
lung cancer, as well as some epithelial cancers, including breast,
colon, gastric and skin carcinoma was originally explained with
de-differentiation mechanisms.84 Reduced lamin expression has
also been reported to correlate with tumor aggressiveness, where
low expression levels of A-type lamins correlated with an increased
recurrence of stage II and stage III colon cancer patients.85,86
However, in other cancers aggressiveness correlates with increased
lamin A/C levels, i.e., in a subset of epithelial cancers, including
ovarian, skin, colorectal and prostate cancer.84,96 Cancer-related
changes in lamin expression mostly account to A-type lamins,
with a small exception for B-type lamins, where subtypes of lung
cancer and neoplasms in the gastrointestinal tract show a decrease
in lamin B1 expression. All together, both lamin up- and downre-
gulations are associated with cancers and thus de-differentiation is
insufficient to explain lamin function with cancer.71,78,84
The correlation of lamin A expression with nuclear stiffness was
demonstrated by a number of technical approaches. Overexpres-
sion of lamin A content in isolated Xenopus oocyte nuclei was
directly associated with nuclear stiffness as demonstrated by atomic
force microscopy (AFM).65,87 Accordingly, deficiency of lamin A/
C in mouse embryonic fibroblasts reduced nuclear rigidity and
integrity as observed by a cellular compression device and nuclear
strain experiments.67,88 In addition, lamin A/C knockdown in
human primary fibroblasts yielded increased nuclear deformation
by micropipette aspiration, with deformation levels similar to to
embryonic stem cells, while B-type lamin levels remained
unchanged.37,67 All these data support the concept that a high
lamin A:B stoichiometry enhances rigidity of the nucleus.89 Inter-
estingly, recent literature also suggests that B1-type lamins contrib-
ute to nuclear stiffness in fibroblasts, accounting to the disease
effects in autosomal dominant leukodystrophy.90 In conclusion,
lamin A expression levels significantly contribute to the overall
stiffness of the nucleus and consequently the entire cell. Lamin A/
C expression is regulated by a number of mechanisms, with the
ECM stiffness as an important contributor.
Impact of ECM stiffness on nuclear rigidity
The overall cellular and nuclear stiffness directly depends on
the rigidity of the underlying or surrounding ECM.91-93 The cell
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senses ECM stiffness by strengthened integrin binding to the
ECM, mechanosensitive focal adhesion proteins that transmit sig-
nals to the cytoskeleton and subsequent reinforcement of actin fila-
ment strength and stiffening.92 Actin cables transmit these signals
via the LINC complex and the nuclear lamina into the nucleus to
switch on mechanosensitive gene expression. One potential trans-
mission mechanism to switch on gene expression occurs through
positional changes of chromatin territories during mechanical
stress.73,94 One example of mechanosensitive gene expression is
the linear positive correlation of lamin A expression with increas-
ing tissues stiffness mediated by the retinoic acid pathway.93
Whereas lamin expression regulation is a relatively slow process
over hours, lamina assemblies can be changed fast in response to
changing stiffnesses of their surrounding by an expression-inde-
pendent mechanism. This is based on a lamin assembly/disassem-
bly balance mediated by fast lamin de-phosphorylation and
phosphorylation processes.93 Increased cell spreading on stiff tis-
sues suppresses lamin A phosphorylation, consequently stabilizing
lamin A assemblies, whereas soft tissue contact supports partial
lamin phosphorylation-dependent disassembly. Together, ECM
stiffness-mediated signaling can affect nuclear deformability
through transcriptional alterations by chromatin dislocations, acti-
vation/expression of stiffness-related genes including lamin A, or
differential regulation of lamin turnover. Overall, nuclear stiffness
is directly determined by chromatin organization, the nucleoskele-
ton (although not further reviewed here) and the level of assem-
bled lamin, and regulated by the rigidity of the ECM
environment. Dependent on these factors, nuclear rigidity can
vary considerably and affect the capacity of a cell to migrate.
Consequences of Nuclear Deformability for Cancer
Cell Migration
Space negotiation during migration is a reciprocal interplay
between physical space and cellular and nuclear adaptation,
respectively, which can both vary considerably. A decrease in
matrix spacing leads to a decay in migration rates (Table 1) and,
likewise, varying nuclear deformability depending on chromatin
organization and nuclear lamina expression might modulate
migration efficacy or arrest.
In regard to chromatin organization, cancer often associates
with increased transcription rate and, in consequence, with con-
comitant nuclear shape alterations, together with increased
nuclear pliability.84 This increased nuclear deformability might
initially hint toward a function for increased migration rates
under confined conditions. Instead, however, chromatin conden-
sation and thus stiffening together with size reduction is favorable
for cell migration.64 A rapid increase in histone methylation at
H4K20me1, H3K27me3 locations leading to heterochromatin
formation is required for the induction of directed migration in a
wound healing assay.63 This hints toward an important structural
role of chromatin to reduce nuclear size and to shape the nucleus
for efficient cell migration in restricted space. Furthermore, chro-
matin is thought to be part of the nucleoskeleton, required for
mechanical coupling of the nucleus to the cytoskeleton to
facilitate efficient cell migration.34,64,73 Thus, chromatin/
nucleoskeleton organization promotes migration most when
keeping the nucleus in a compact form of smaller size.
Next, as summarized above, the progression of different can-
cers is often accompanied by an up-or downregulation of lamins,
however, the impact of lamin expression on cancer invasion and
migration only begins to be clarified. Currently, a growing body
of evidence, based on in vitro data, hints toward an important
role for lamin A/C in the migration of different cell types. Most
data have been collected using 2-dimensional wound healing
assays together with transmigration or synthetic channel assays of
defined porosity. A number of studies show that enhanced lamin
expression directly correlates with increased migration efficacy,
e.g. in ovarian and colorectal cancers.95,96 Others show, with
growing evidence, an inverse correlation of lamin A/C expression
with migration efficacy in line with the principle that enhanced
nuclear pliability is associated with increased invasion.79,89,97,98
Some of the contrasting outcomes may originate from the differ-
ent physical dimensionalities of the migration substrates and the
fact that lamin modulation-induced disturbed mechanocoupling
cannot be compensated on a 2D substrate surface. Thus downre-
gulation of lamin A/C which is associated with increased nuclear
deformability may promote tumor cell dissemination, particu-
larly in dense tissues, which might be, however, on the cost of
cell survival.89,99 In conclusion, chromatin organization regulates
the density and size, and lamin A/C expression the pliability of
the nucleus, and together impact cell migration in vitro.
Conclusion
The concept of space negotiation, summarized in this review, is
valid for metastatic cancer invasion through the dense ECM of reac-
tive tumor stroma, but applies in general to all cell types migrating
through dense tissue spaces, such as fibroblasts or immune cells.
Whereas tumor-related ECM remodeling processes were studied
extensively during the last decades, the mechanisms of cell, and in
particular nuclear deformation, to adapt to small available tissue
spaces during migration has only recently begun to be investigated
and still leaves open questions. The expression levels of lamins,
most importantly lamin A/C, correlate with nuclear stiffness, how-
ever, do not unambiguously correlate with the capacity to invade.
In addition, for the progression of various human cancers both
lamin up- and downregulation have been reported. It is therefore
not yet possible to clearly assign lamin expression rates to cancer
invasion rates, survival and metastasis formation in the living organ-
ism.71,84,89 Systematic screenings of different tumor locations, such
as main mass, non-invasive, invasive or metastatic zones may help
to elucidate the role of lamins in disease progression. Another,
related, future goal might be to deeper address the role of nucleus-
enveloping as well as intranuclear actin structures that help to trans-
port and deform the nucleus for migration against confining resis-
tance within 3-dimensional structures. As a recent achievement it
was shown that nuclear actin organization by nuclear Rac1 contrib-
utes to the ability of the nucleus to deform and drive invasion.100 It
remains a future challenge to test the relevance of actin- and lamin-
mediated cell mechanics in the context of invasive space negotiation
to better understand -and target- metastatic invasion in vivo.
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